H Klumpp1, D A Fitzgerald1, M Angstadt2, D Post1, K L Phan1. 1. Mood and Anxiety Disorders Research Program, Department of Psychiatry,University of Illinois at Chicago,Chicago, IL,USA. 2. Department of Psychiatry,University of Michigan,Ann Arbor, MI,USA.
Abstract
BACKGROUND: Individuals with generalized social anxiety disorder (gSAD) exhibit attentional bias to salient stimuli, which is reduced in patients whose symptoms improve after treatment, indicating that mechanisms of bias mediate treatment success. Therefore, pre-treatment activity in regions implicated in attentional control over socio-emotional signals (e.g. anterior cingulate cortex, dorsolateral prefrontal cortex) may predict response to cognitive behavioral therapy (CBT), evidence-based psychotherapy for gSAD. METHOD: During functional magnetic resonance imaging, 21 participants with gSAD viewed images comprising a trio of geometric shapes (circles, rectangles or triangles) alongside a trio of faces (angry, fearful or happy) within the same field of view. Attentional control was evaluated with the instruction to 'match shapes', directing attention away from faces, which was contrasted with 'match faces', whereby attention was directed to emotional faces. RESULTS: Whole-brain voxel-wise analyses showed that symptom improvement was predicted by enhanced pre-treatment activity in the presence of emotional face distractors in the dorsal anterior cingulate cortex and dorsal medial prefrontal cortex. Additionally, CBT success was foretold by less activity in the amygdala and/or increased activity in the medial orbitofrontal gyrus during emotion processing. CONCLUSIONS: CBT response was predicted by pre-treatment activity in prefrontal regions and the amygdala. The direction of activity suggests that individuals with intact attentional control in the presence of emotional distractors, regulatory capacity over emotional faces and/or less reactivity to such faces are more likely to benefit from CBT. Findings indicate that baseline neural activity in the context of attentional control and emotion processing may serve as a step towards delineating mechanisms by which CBT exerts its effects.
BACKGROUND: Individuals with generalized social anxiety disorder (gSAD) exhibit attentional bias to salient stimuli, which is reduced in patients whose symptoms improve after treatment, indicating that mechanisms of bias mediate treatment success. Therefore, pre-treatment activity in regions implicated in attentional control over socio-emotional signals (e.g. anterior cingulate cortex, dorsolateral prefrontal cortex) may predict response to cognitive behavioral therapy (CBT), evidence-based psychotherapy for gSAD. METHOD: During functional magnetic resonance imaging, 21 participants with gSAD viewed images comprising a trio of geometric shapes (circles, rectangles or triangles) alongside a trio of faces (angry, fearful or happy) within the same field of view. Attentional control was evaluated with the instruction to 'match shapes', directing attention away from faces, which was contrasted with 'match faces', whereby attention was directed to emotional faces. RESULTS: Whole-brain voxel-wise analyses showed that symptom improvement was predicted by enhanced pre-treatment activity in the presence of emotional face distractors in the dorsal anterior cingulate cortex and dorsal medial prefrontal cortex. Additionally, CBT success was foretold by less activity in the amygdala and/or increased activity in the medial orbitofrontal gyrus during emotion processing. CONCLUSIONS: CBT response was predicted by pre-treatment activity in prefrontal regions and the amygdala. The direction of activity suggests that individuals with intact attentional control in the presence of emotional distractors, regulatory capacity over emotional faces and/or less reactivity to such faces are more likely to benefit from CBT. Findings indicate that baseline neural activity in the context of attentional control and emotion processing may serve as a step towards delineating mechanisms by which CBT exerts its effects.
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Jonathan R T Davidson; Edna B Foa; Jonathan D Huppert; Francis J Keefe; Martin E Franklin; Jill S Compton; Ning Zhao; Kathryn M Connor; Thomas R Lynch; Kishore M Gadde Journal: Arch Gen Psychiatry Date: 2004-10
Authors: Katie L Burkhouse; Autumn Kujawa; Kate Keenan; Heide Klumpp; Kate D Fitzgerald; Christopher S Monk; K Luan Phan Journal: Psychiatry Res Neuroimaging Date: 2017-03-09 Impact factor: 2.376
Authors: Katie L Burkhouse; Autumn Kujawa; Bobby Hosseini; Heide Klumpp; Kate D Fitzgerald; Scott A Langenecker; Christopher S Monk; K Luan Phan Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2018-03-10 Impact factor: 5.067
Authors: Jennie M Kuckertz; Nader Amir; Joseph W Boffa; Ciara K Warren; Susan E M Rindt; Sonya Norman; Vasudha Ram; Lauretta Ziajko; Jennifer Webb-Murphy; Robert McLay Journal: Behav Res Ther Date: 2014-09-16
Authors: Katherine S Young; Richard T LeBeau; Andrea N Niles; Kean J Hsu; Lisa J Burklund; Bita Mesri; Darby Saxbe; Matthew D Lieberman; Michelle G Craske Journal: J Affect Disord Date: 2018-08-18 Impact factor: 4.839
Authors: Katie L Burkhouse; Autumn Kujawa; Heide Klumpp; Kate D Fitzgerald; Christopher S Monk; K Luan Phan Journal: J Child Psychol Psychiatry Date: 2016-11-08 Impact factor: 8.982